Allovir Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Allovir Inc
TickerKLRS
CIK #0001754068
CUSIP482929106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address139 Main Street, Suite 500, Cambridge, MA 02142
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Allovir Inc 2019-05-22 121.3 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Viracyte Inc 2018-10-02 30.0 M Exemption: 506(b) · Remaining: $20,000,000 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001754068] 10-K
[0001754068] 10-Q
[0001754068] 3
[0001754068] 4
[0001754068] 5
[0001754068] 8-K
[0001754068] D
[0001754068] SC 13D
[0001754068] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
RTW Investments LP Kalaris Therapeutics Inc [2026-02-17] 0.0
Samsara Biocapital LP Kalaris Therapeutics Inc [2025-03-25] 0.0
Octagon Capital Advisors LP Allovir Inc [2024-10-11] 0.7
EcoR1 Capital LLC Allovir Inc [2024-02-01] 0.3
Wilson John Robert Allovir Inc [2024-01-09] 8.98
Gilead Sciences Inc Allovir Inc [2022-08-08] 14.8
Globeways Holdings II Ltd Allovir Inc [2022-08-05] 2.2
Artal International SCA Allovir Inc [2022-08-05] 6.0
Globeways Holdings II Ltd Allovir Inc [2020-08-13] 2.1
Elevatebio LLC Allovir Inc [2020-08-13] 20.6
FMR LLC Allovir Inc [2020-08-10] 0.0
Form 3/4/5 Filer 2011 - 2026
Akkaraju Srinivas
Kalaris Therapeutics Inc
Hallal David
Dybbs Michael
Patterson Leone D
Adamis Anthony P
Jovan-Embiricos Morana
Ferrara Napoleone
Samsara BioCapital LP
Samsara Opportunity Fund GP LLC
Samsara BioCapital GP LLC
Samsara Opportunity Fund LP
Hagen Brett R
Feinsod Matthew
Oxtoby Andrew
Gall Matthew
Patel Samir Chandrakant
Miller Edward
Sinha Vikas
Brainard Diana
Brenner Malcolm
Adams Derek N
Bornstein Jeffrey S
Vera Juan
Tomasello Shawn
Piccina Cintia
Gilead Sciences Inc
Leen Ann M
van BEEK Jeroen B
Atillasoy Ercem
F2 - TPO Investments LLC
F2 Bioscience AV 2022 LLC
Globeways Holdings Ltd
F2 MC LLC
F2 Capital I 2020
Globeways Holdings II Ltd
F2 MG Ltd
ElevateBio LLC
Gadicke Ansbert
Melian Agustin
Wilson John Robert
Redmile Group LLC
Green Jeremy
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hagen Brett R
Common Stock
2026-03-20 Sell 1,915 $6.72 12,869
Oxtoby Andrew
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 222,000 $0.00
Hagen Brett R
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 60,800 $0.00
Gall Matthew
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 95,000 $0.00
Feinsod Matthew
Stock Option (Right to Buy) · derivative
2026-03-19 Grant 135,000 $0.00
Samsara Opportunity Fund GP LLC +2
Common Stock
2025-12-22 Grant 1,500,000 $10.00 15,000,000
Samsara BioCapital LP +4
Common Stock
2025-12-18 Buy 479,847 $10.42 5,000,006
Gall Matthew
Stock Option (Right to Buy) · derivative
2025-11-03 Grant 235,000 $0.00
Akkaraju Srinivas
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Ferrara Napoleone
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Hagen Brett R
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 50,262 $0.00
Patel Samir Chandrakant
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Oxtoby Andrew
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 287,000 $0.00
Dybbs Michael
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Patterson Leone D
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Jovan-Embiricos Morana
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Hallal David
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
Feinsod Matthew
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 101,000 $0.00
Feinsod Matthew
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 70,551 $0.00
Adamis Anthony P
Stock Option (Right to Buy) · derivative
2025-04-10 Grant 18,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 58 18,714,356
2025-12-31 51 18,013,560
2025-09-30 32 13,223,008
2025-06-30 31 13,362,438
2025-03-31 33 13,874,351
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com